Clinical TrialsSearch results
Number of results: 61127
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Work for a university hospital nurse occupation continued and sympatly scale score relation
- no
- Kansai Medical University Hospital Nursing unit
- 2018-10-20
Recruiting
- WMU-NPC-1
- Patients with cutaneous manifestation with vascular
- Jinnin Masatoshi
- 2021-11-26
Other
- WJOG7512L:A randomized phase III study of maintenance therapy with TS-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus TS-1 for advanced or relapsed squamous cell carcinoma of the lung
- Advanced or relapsed squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2013-04-02
Other
- WJOG6510GTR: Study of genetic biomarkers to predict efficacy in patients with wild-type KRAS metastatic colorectal cancer receiving Panitumumab + Irinotecan or Cetuximab + Irinotecan
- Advanced colorectal cancer
- West Japan Oncology Group
- 2012-08-28
Other
- WJOG6510G : Randomized phase II study of panitumumab + irinotecan versus cetuximab + irinotecan in Patients Wild-Type KRAS Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
- advanced colorectal cancer
- West Japan Oncology Group
- 2011-11-01
Other
- WJOG11118L
- Lung Cancer
- Hirotsugu Kenmotsu
- 2020-09-29
Recruiting
- WJOG 14720L
- Untreated ALK-rearranged non-squamous non-small cell lung cancer
- Hirotsugu Kenmotsu
- 2021-11-22
Other
- Without antibiotic prophylaxis in children with mild vesicoureteral reflux (grade 0-2) after a first urinary tract infection. : A multicenter trial.
- Urinary tract infection
- Tokyo Metropolitan Children's Medical Center
- 2009-03-27
Other
- Withdrawal of immunomodulator in Crohn's disease treated with adalimumab and immnomodulator : a multicenter randomized trial(Diamond2 study).
- Crohn`s disease
- Department of Internal Medicine, School of Medicine, Keio University
- 2012-12-21
Other
- Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis
- Type 2 diabetes
- National Center for Global Health and Medicine Kohnodai Hospital
- 2015-06-26